Skip to main content

Articles

Page 59 of 335

  1. Preoperative prediction of microsatellite instability (MSI) status in colorectal cancer (CRC) patients is of great significance for clinicians to perform further treatment strategies and prognostic evaluation....

    Authors: Mingliang Ying, Jiangfeng Pan, Guanghong Lu, Shaobin Zhou, Jianfei Fu, Qinghua Wang, Lixia Wang, Bin Hu, Yuguo Wei and Junkang Shen
    Citation: BMC Cancer 2022 22:524
  2. Runt-related transcription factor 1 (RUNX1) is a vital regulator of mammalian expression. Despite multiple pieces of evidence indicating that dysregulation of RUNX1 is a common phenomenon in human cancers, the...

    Authors: Zhouting Tuo, Ying Zhang, Xin Wang, Shuxin Dai, Kun Liu, Dian Xia, Jinyou Wang and Liangkuan Bi
    Citation: BMC Cancer 2022 22:523
  3. Cervical screening saves approximately 5000 lives annually in England. However, screening rates have been falling continuously, and coverage in London is particularly low (64.7%). While demographic predictors ...

    Authors: Gaby Judah, Faisal Dilib, Ara Darzi and Sarah Huf
    Citation: BMC Cancer 2022 22:522
  4. Patients have significantly lower QoL scores after pancreatic resection due to cancer in the physical and psychological domains compared to healthy controls or other cancer patients. Intensified physiotherapy ...

    Authors: Dirk Weyhe, Dennis Obonyo, Verena Uslar and Navid Tabriz
    Citation: BMC Cancer 2022 22:520
  5. Cytochrome P450 (CYP) and glutathione S transferases (GSTs) are important biotransforming enzymes responsible for detoxification of anticancer drugs and carcinogens. Polymorphisms in these enzymes may greatly ...

    Authors: Samina Naz Mukry, Aneeta Shahni, Uzma Zaidi and Tahir Sultan Shamsi
    Citation: BMC Cancer 2022 22:519
  6. Hepatocellular carcinoma (HCC) is one of the most prevalent types of cancer and is responsible for close to one million annual deaths globally. In Pakistan, HCC accounts for 10.7% of cancer incidence. Prior st...

    Authors: Maria Shabbir, Yasmin Badshah, Khushbukhat Khan, Janeen H. Trembley, Areeb Rizwan, Fatima Faraz, Syeda Alveena Shah, Mahrukh Farooqi, Naeem Mahmood Ashraf, Tayyaba Afsar, Ali Almajwal, Nawaf W. Alruwaili and Suhail Razak
    Citation: BMC Cancer 2022 22:518
  7. Transarterial chemoembolization (TACE) is the standard treatment for intermediate stage hepatocellular carcinoma (HCC) (Barcelona Clinic Liver Cancer [BCLC] B). However, it often leads to a poor prognosis and ...

    Authors: Satoshi Kobayashi, Taito Fukushima, Makoto Ueno, Satoshi Moriya, Makoto Chuma, Kazushi Numata, Kota Tsuruya, Shunji Hirose, Tatehiro Kagawa, Nobuhiro Hattori, Tsunamasa Watanabe, Kotaro Matsunaga, Michihiro Suzuki, Haruki Uojima, Hisashi Hidaka, Chika Kusano…
    Citation: BMC Cancer 2022 22:517
  8. Approximately 20–33% of all cancer patients are treated with acid-reducing agents (ARAs), most commonly proton pump inhibitors (PPIs), to reduce gastroesophageal reflux disease symptoms. Palbociclib and riboci...

    Authors: Kadir Eser, Arif Hakan Önder, Emel Sezer, Timuçin Çil, Ali İnal, Banu Öztürk, Vehbi Erçolak, Berna Bozkurt Duman, Halil Çelik, Tolga Köşeci and Oğuzhan Kesen
    Citation: BMC Cancer 2022 22:516
  9. Monitoring proteinuria is important for the management of patients with cancer treated with anti-vascular endothelial growth factor (VEGF) or anti-VEGF receptor (VEGFR) inhibitors (VEGF/Ri). Here we investigat...

    Authors: Michio Nakamura, Taro Funakoshi, Shigeki Kataoka, Takahiro Horimatsu, Yoshitaka Nishikawa, Takeshi Matsubara, Takuro Mizukami, Tomoyuki Goto, Kenji Tsuchihashi, Eishi Baba, Takehiko Tsumura, Yoshiaki Mihara, Tetsuya Hamaguchi, Motoko Yanagita and Manabu Muto
    Citation: BMC Cancer 2022 22:515
  10. Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) are the current standard of care for advanced or metastatic non-small cell lung cancer (NSCLC) patients harboring EGFR activating mutation...

    Authors: Ziyi Xu, Chengcheng Liu, Yixiang Zhu, Zihua Zou, Tongji Xie, Puyuan Xing, Le Wang and Junling Li
    Citation: BMC Cancer 2022 22:514
  11. The revised 8th Edition American Joint Committee on Cancer (AJCC) Head and Neck Staging Manual distinguishes HPV-mediated from non-HPV-mediated oropharyngeal cancer (OpSCC). The objective was to analyze OpSCC ...

    Authors: X. J. David Lu, Emmanuel Jackson, Jason Chew, Sally Nguyen, Jonn Wu, Catherine F. Poh and Eitan Prisman
    Citation: BMC Cancer 2022 22:513
  12. Indian natural products have been anecdotally used for cancer treatment but with limited efficacy. To better understand their mechanism, we examined the publicly available data for the activity of Indian natur...

    Authors: Hari Sankaran, Simarjeet Negi, Lisa M. McShane, Yingdong Zhao and Julia Krushkal
    Citation: BMC Cancer 2022 22:512
  13. Acquired resistance to approved tyrosine kinase inhibitors limits their clinical use in patients with gastrointestinal stromal tumor (GIST). This study investigated the safety, tolerability and efficacy of alp...

    Authors: Maria A. Pantaleo, Michael C. Heinrich, Antoine Italiano, Claudia Valverde, Patrick Schöffski, Giovanni Grignani, Anna K. L. Reyners, Sebastian Bauer, Peter Reichardt, Daniel Stark, Ghimja Berhanu, Ulrike Brandt, Tommaso Stefanelli and Hans Gelderblom
    Citation: BMC Cancer 2022 22:511
  14. Better prognostic outcome is closely correlated with early detection of bladder cancer. Current non-invasive urianalysis relies on simultaneously testing multiple methylation markers to achieve relatively high...

    Authors: Leihong Deng, Haichao Chao, Huanhuan Deng, Zhaojun Yu, Rongsong Zhao, Longwu Huang, Yun Gong, Yueting Zhu, Qingping Wang, Feng Li, Lirong Liu, Lei He, Zhimin Tang, Caizhi Liao, Yan Qi, Xianshu Wang…
    Citation: BMC Cancer 2022 22:510
  15. To investigate the clinicopathological characteristics, diagnoses, treatments, and outcomes of a special type of gestational trophoblastic neoplasia (GTN) which only has extrauterine metastases without uterine...

    Authors: Jingnan Li, Yu Wang, Bingjian Lu, Weiguo Lu, Xing Xie and Yuanming Shen
    Citation: BMC Cancer 2022 22:509
  16. A high percentage of epithelial ovarian cancers (EOC) express the estrogen receptor (ER), which is an ideal target for endocrine therapy. Letrozole is a proven, potent aromatase inhibitor, extensively tested a...

    Authors: Pamela M. J. McLaughlin, Maximilian Klar, Tibor A. Zwimpfer, Gilles Dutilh, Marcus Vetter, Christian Marth, Andreas du Bois, Carmen Schade-Brittinger, Alexander Reuss, Claudine Bommer, Christian Kurzeder and Viola Heinzelmann-Schwarz
    Citation: BMC Cancer 2022 22:508
  17. The MyPeBS study is an ongoing randomised controlled trial testing whether a risk-stratified breast cancer screening strategy is non-inferior, or eventually superior, to standard age-based screening at reducin...

    Authors: Alexandra Roux, Rachel Cholerton, Jonathan Sicsic, Nora Moumjid, David P. French, Paolo Giorgi Rossi, Corinne Balleyguier, Michal Guindy, Fiona J. Gilbert, Jean-Benoit Burrion, Xavier Castells, David Ritchie, Debbie Keatley, Camille Baron, Suzette Delaloge and Sandrine de Montgolfier
    Citation: BMC Cancer 2022 22:507
  18. Preoperative chemoradiotherapy (CRT) with CROSS regimen has been the recommended treatment for locally advanced esophageal squamous cell carcinoma (ESCC). The addition of programmed cell death protein 1 (PD-1)...

    Authors: Yang Yang, Li Zhu, Yan Cheng, Zhichao Liu, Xiaoyue Cai, Jinchen Shao, Ming Zhang, Jun Liu, Yifeng Sun, Yin Li, Jun Yi, Bentong Yu, Hongjing Jiang, Hezhong Chen, Hong Yang, Lijie Tan…
    Citation: BMC Cancer 2022 22:506
  19. A first pilot study showed that an image-guided navigation system could improve resection margin rates in locally advanced (LARC) and locally recurrent rectal cancer (LRRC) patients. Incremental surgical innov...

    Authors: Melanie Lindenberg, Astrid Kramer, Esther Kok, Valesca Retèl, Geerard Beets, Theo Ruers and Wim van Harten
    Citation: BMC Cancer 2022 22:504
  20. Many studies have recently reported the association of concomitant medications with the response and survival in patients with non-small-cell lung cancer (NSCLC) treated with cancer immunotherapy. However, the...

    Authors: Kazuki Takada, Mototsugu Shimokawa, Shinkichi Takamori, Shinichiro Shimamatsu, Fumihiko Hirai, Tetsuzo Tagawa, Tatsuro Okamoto, Motoharu Hamatake, Yuko Tsuchiya-Kawano, Kohei Otsubo, Koji Inoue, Yasuto Yoneshima, Kentaro Tanaka, Isamu Okamoto, Yoichi Nakanishi and Masaki Mori
    Citation: BMC Cancer 2022 22:503
  21. The National Comprehensive Cancer Network recommends that patients with hormone receptor-positive early breast cancer be considered for adjuvant endocrine therapy (ET) after primary treatment like surgical exc...

    Authors: Jacqueline Brown, Savannah Scardo, Michael Method, Dan Schlauch, Amanda Misch, Shaita Picard, Erika Hamilton, Suzanne Jones, Howard Burris and David Spigel
    Citation: BMC Cancer 2022 22:502
  22. Ewing sarcoma (ES) is sensitive to systemic therapy, including chemotherapy and anti-angiogenesis Tyrosine Kinase Inhibitors(aaTKIs). However, the prognosis of patients with metastatic disease remains poor. Re...

    Authors: Jie Xu, Xin Zhi, Lu Xie, Xin Sun, Xingyu Liu, Kuisheng Liu and Wei Guo
    Citation: BMC Cancer 2022 22:500
  23. Atypical teratoid/rhabdoid tumor (AT/RT) is a malignant pediatric tumor of the central nervous system (CNS) with high recurrence and low survival rates that is often misdiagnosed. MicroRNAs (miRNAs) are involv...

    Authors: Xinke Xu, Hongyao Yuan, Junping Pan, Wei Chen, Cheng Chen, Yang Li and Fangcheng Li
    Citation: BMC Cancer 2022 22:499
  24. Tubulin alpha-1c chain (TUBA1C), a subtype of α-tubulin, has been shown to be involved in cell proliferation and cell cycle progression in several cancers and to influence cancer development and prognosis. How...

    Authors: Xinyao Hu, Hua Zhu, Biao Chen, Xiaoqin He, Yang Shen, Xiaoyu Zhang, Yangtao Xu and Ximing Xu
    Citation: BMC Cancer 2022 22:498
  25. Current cancer immunotherapies have made tremendous impacts but generally lack high response rates, especially in ovarian cancer. New therapies are needed to provide increased benefits. One understudied approa...

    Authors: Evan B. Glass, Alyssa A. Hoover, Kennady K. Bullock, Matthew Z. Madden, Bradley I. Reinfeld, Whitney Harris, Dominique Parker, Demetra H. Hufnagel, Marta A. Crispens, Dineo Khabele, W. Kimryn Rathmell, Jeffrey C. Rathmell, Andrew J. Wilson, Todd D. Giorgio and Fiona E. Yull
    Citation: BMC Cancer 2022 22:497
  26. To rethink the clinical significance of standardized uptake values (SUVs) of nasopharyngeal carcinoma (NPC) on 18F-fluorodeoxyglucose (18F-FDG) positron-emission tomography (PET).

    Authors: Xiufang Qiu, Haixia Wu, Ting Xu, Shihan Xie, Ziqing You, Yixin Hu, Yinghong Zheng, Zewei Liang, Chaoxiong Huang, Li Yi, Li Li, Jing Liu, Zhaodong Fei and Chuanben Chen
    Citation: BMC Cancer 2022 22:495
  27. TMPRSS2-ERG gene rearrangement, the most common E26 transformation specific (ETS) gene fusion within prostate cancer, is known to contribute to the pathogenesis of this disease and carries diagnostic annotations ...

    Authors: Vipulkumar Dadhania, Daniel Gonzalez, Mustafa Yousif, Jerome Cheng, Todd M. Morgan, Daniel E. Spratt, Zachery R. Reichert, Rahul Mannan, Xiaoming Wang, Anya Chinnaiyan, Xuhong Cao, Saravana M. Dhanasekaran, Arul M. Chinnaiyan, Liron Pantanowitz and Rohit Mehra
    Citation: BMC Cancer 2022 22:494
  28. Breast cancer (BC) has particular characteristics in young women, with diagnosis at more advanced stages, a poorer prognosis and highly aggressive tumors. In NeoFit, we will use an activity tracker to identify...

    Authors: Lidia Delrieu, Anne-Sophie Hamy, Florence Coussy, Amyn Kassara, Bernard Asselain, Juliana Antero, Paul De Villèle, Elise Dumas, Nicolas Forstmann, Julien Guérin, Judicael Hotton, Christelle Jouannaud, Maud Milder, Armand Leopold, Adrien Sedeaud, Pauline Soibinet…
    Citation: BMC Cancer 2022 22:493
  29. The management of meningiomas is challenging, and the role of postoperative radiotherapy is not standardized.

    Authors: Galina Farina Fischer, Detlef Brügge, Nicolaus Andratschke, Brigitta Gertrud Baumert, Davide Giovanni Bosetti, Francesca Caparrotti, Evelyn Herrmann, Alexandros Papachristofilou, Susanne Rogers, Lucia Schwyzer, Daniel Rudolf Zwahlen, Thomas Hundsberger and Paul Martin Putora
    Citation: BMC Cancer 2022 22:492
  30. High medication literacy is the basis of rational medication application and is essential for the management of severe adverse drug reactions. The objective of the present study was to assess the level of medi...

    Authors: Ruofei Du, Huashan Yang, Huiyue Zhou, Lixia Ma, Mikiyas Amare Getu, Changying Chen and Tao Wang
    Citation: BMC Cancer 2022 22:491
  31. Sonic Hedgehog (SHH) pathway dysregulation is implicated in basal cell carcinoma (BCC) development. To evaluate the possible wider role of SHH gene variants in skin carcinogenesis, we assessed associations of ...

    Authors: Astrid J. Rodriguez-Acevedo, Annika Antonsson, Upekha E. Liyanage, Maria Celia Hughes, Scott Gordon, Jolieke van der Pols and Adele C. Green
    Citation: BMC Cancer 2022 22:490
  32. Pancreatic cancer is one of the most lethal tumors. The aim of this study is to provide an effective therapeutic discovery platform for pancreatic cancer by establishing and characterizing patient-derived orga...

    Authors: Sadanori Watanabe, Akitada Yogo, Tsuguteru Otsubo, Hiroki Umehara, Jun Oishi, Toru Kodo, Toshihiko Masui, Shigeo Takaishi, Hiroshi Seno, Shinji Uemoto and Etsuro Hatano
    Citation: BMC Cancer 2022 22:489
  33. Emerging evidence has identified miR-138 as a tumor suppressor that can suppress the proliferation of various cancers. Meanwhile, the cause of abnormal miR-138 expression in cervical cancer remains uncertain. ...

    Authors: Rui Chen, Qiyu Gan, Shuting Zhao, Dongrui Zhang, Shunli Wang, Lili Yao, Min Yuan and Jingxin Cheng
    Citation: BMC Cancer 2022 22:488
  34. Several studies have demonstrated that right-sided tumors have poorer prognosis than left-sided tumors in patients with unresectable colorectal cancer (CRC). The predictive ability of the tumor sidedness in CR...

    Authors: Shinya Abe, Kazushige Kawai, Hiroaki Nozawa, Kazuhito Sasaki, Koji Murono, Shigenobu Emoto, Tsuyoshi Ozawa, Yuichiro Yokoyama, Yuzo Nagai, Hiroyuki Anzai, Hirofumi Sonoda, Shinichi Yamauchi, Kenichi Sugihara and Soichiro Ishihara
    Citation: BMC Cancer 2022 22:486
  35. The capacity for invasive tissue biopsies followed by histopathology diagnosis in sub-Saharan Africa is severely limited. Consequently, many cancer patients are diagnosed late and outcomes are poor. Here, we p...

    Authors: Ismail D. Legason, Martin D. Ogwang, Clara Chamba, Elifuraha Mkwizu, Claire El Mouden, Hadija Mwinula, Lulu Chirande, Anna Schuh and Faraja Chiwanga
    Citation: BMC Cancer 2022 22:484
  36. A critical challenge in current acute lymphoblastic leukemia (ALL) therapy is treatment intensification in order to reduce the relapse rate in the subset of patients at the highest risk of relapse. The year-lo...

    Authors: Linea Natalie Toksvang, Bodil Als-Nielsen, Christopher Bacon, Ruta Bertasiute, Ximo Duarte, Gabriele Escherich, Elín Anna Helgadottir, Inga Rinvoll Johannsdottir, Ólafur G. Jónsson, Piotr Kozlowski, Cecilia Langenskjöld, Kristi Lepik, Riitta Niinimäki, Ulrik Malthe Overgaard, Mari Punab, Riikka Räty…
    Citation: BMC Cancer 2022 22:483
  37. More than 60% of oligo-recurrent prostate cancer (PCa) patients treated with metastasis-directed radiotherapy (MDRT) develop biochemical recurrence within 2 years. This recurrence rate emphasises the need for ...

    Authors: J. Janssen, F. H. E. Staal, C. L. Brouwer, J. A. Langendijk, I. J. de Jong, R. J. A. van Moorselaar, E. Schuit, J. F. Verzijlbergen, R. J. Smeenk and S. Aluwini
    Citation: BMC Cancer 2022 22:482
  38. Acute promyelocytic leukaemia (APL) is a unique subtype of acute myeloid leukaemia (AML) characterized by haematopoietic failure caused by the accumulation of abnormal promyelocytic cells in bone marrow (BM). ...

    Authors: Guiran Wang, Guiling Yan, Kanru Sang, Huijie Yang, Ni Sun, Yuanyuan Bai, Feng Xu, Xiaoqun Zheng and Zhanguo Chen
    Citation: BMC Cancer 2022 22:481
  39. We conducted a Pattern-of-care (POC) study at two premier-most public-funded oncology centers in Morocco to evaluate delays in care continuum and adherence to internationally accepted treatment guidelines of c...

    Authors: Abdellatif Benider, Karima Bendahhou, Catherine Sauvaget, Hind Mrabti, Farida Selmouni, Richard Muwonge, Leila Alaoui, Eric Lucas, Youssef Chami, Loubna Abousselham, Maria Bennani, Hassan Errihani, Rengaswamy Sankaranarayanan, Rachid Bekkali and Partha Basu
    Citation: BMC Cancer 2022 22:479
  40. Mutations and fusions in Fibroblast Growth Factor Receptor 3 (FGFR3) occur in 10–20% of metastatic urothelial carcinomas and confer sensitivity to FGFR inhibitors. However, responses to these agents are often sho...

    Authors: Andrew J. Weickhardt, David K. Lau, Margeaux Hodgson-Garms, Austen Lavis, Laura J. Jenkins, Natalia Vukelic, Paul Ioannidis, Ian Y. Luk and John M. Mariadason
    Citation: BMC Cancer 2022 22:478
  41. Platelet counts varied over time after induction chemotherapy. We aimed to investigate the different trajectories of platelet counts after the first cycle of induction chemotherapy in patients newly diagnosed ...

    Authors: Yazhen Bi, Zhaohui Wang, Saran Feng, Yan Wang, Yang Zhao, Hong Li, Jingyi Yu, Qian Liu, Chuansheng Zhu and Mingzhuo Li
    Citation: BMC Cancer 2022 22:477

    The Correction to this article has been published in BMC Cancer 2022 22:647

  42. Social media platforms are increasingly being used by stakeholders to generate, access, and share health-related information and experiences. Lung cancer is the most common cancer, impacting > 2 million patien...

    Authors: Ana Rodrigues, Jyoti Chauhan, Alexandros Sagkriotis, Sathyaraj Aasaithambi and Michele Montrone
    Citation: BMC Cancer 2022 22:475

Featured videos

View featured videos from across the BMC-series journals